Advertisement

National and State-Specific Td and Tdap Vaccination of Adult Populations

Published:November 21, 2015DOI:https://doi.org/10.1016/j.amepre.2015.09.033

      Introduction

      The Advisory Committee on Immunization Practices recommends a single dose of tetanus, diphtheria, and acellular pertussis vaccine (Tdap) for adults followed by tetanus and diphtheria toxoids (Td) booster doses every 10 years thereafter. This study assessed recent Td and Tdap vaccination among adult populations.

      Methods

      The 2013 Behavioral Risk Factor Surveillance System data were analyzed in 2015 to assess Td and Tdap vaccination coverage among adults at national and state levels. Multivariable logistic regression and predictive marginal models were performed to identify factors independently associated with vaccination.

      Results

      Overall, national vaccination coverage among adults aged ≥18 years for Td was 57.5% and for Tdap was 28.9%. Among states, Td vaccination coverage ranged from 47.8% in Nevada to 73.1% in Minnesota, and Tdap coverage ranged from 17.7% in Mississippi to 47.6% in Minnesota. Characteristics independently associated with an increased likelihood of Tdap vaccination among adults aged ≥18 years were younger age; being female; American Indian/Alaska Native race; being never married; higher education; not being in the workforce; reporting a household income ≥$75,000; living in the West or Midwest U.S.; reporting excellent, very good, good, or fair health; having health insurance; having a healthcare provider; having a routine checkup in the previous year; receipt of influenza vaccination in the previous year; and having ever received pneumococcal vaccination.

      Conclusions

      By 2013, Td and Tdap vaccination coverage were 57.5% and 28.9%, respectively. Coverage varied by state. Implementation of evidence-based programs is needed to improve Td and Tdap vaccination levels among adult populations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • CDC
        Pertussis epidemic—Washington, 2012.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 517-522
      1. CDC. Pertussis outbreak trends. www.cdc.gov/pertussis/outbreaks/trends.html. Accessed January 8, 2015.

        • Miller B.L.
        • Kretsinger K.
        • Euler G.L.
        • Lu P.J.
        • Ahmed F.
        Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007.
        Vaccine. 2011; 29: 3850-3856https://doi.org/10.1016/j.vaccine.2011.03.058
        • CDC
        Non-influenza vaccination coverage among adults.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 95-102
        • CDC
        Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
        MMWR Recomm Rep. 2006; 55: 1-33
        • CDC
        Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 13-15
        • CDC
        Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine in adults aged 65 years and older from the Advisory Committee on Immunization Practices, 2012.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 468-470
      2. CDC. BRFSS: overview—BRFSS 2013. www.cdc.gov/brfss/annual_data/2013/pdf/Overview_2013.pdf. Accessed August 12, 2015.

        • CDC
        Methodological changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 410-413
      3. CDC. BRFSS—2013 summary data quality report. www.cdc.gov/brfss/annual_data/2013/pdf/2013_DQR.pdf. Accessed August 12, 2015.

        • CDC
        Tetanus and pertussis vaccination coverage among adults aged ≥18 years—United States, 1999 and 2008.
        MMWR Morb Mortal Wkly Rep. 2010; 59: 1302-1306
      4. CDC. Vaccines and immunizations: tetanus. www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html. Accessed January 6, 2015.

        • CDC
        Tetanus surveillance—United States, 2001—2008.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 365-369
      5. CDC. Statistics and surveillance: 2009 adult vaccination coverage, the National Health Interview Survey (NHIS). www.cdc.gov/vaccines/imz-managers/coverage/nhis/2009-nhis.html. Accessed January 15, 2015.

        • CDC
        Adult vaccination coverage, United States, 2010.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 66-72
        • CDC
        Non-influenza vaccination coverage among adults—United States, 2011.
        MMWR Morb Mortal Wkly Rep. 2013; 62: 66-72
        • CDC
        Noninfluenza vaccination coverage among adults—United States, 2013.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 95-102
        • Klaiman T.
        • Ibrahim J.K.
        State health department structure and pandemic planning.
        J Public Health Manag Pract. 2010; 16: E1-E7https://doi.org/10.1097/PHH.0b013e3181b83475
        • Nelson D.E.
        • Bland S.
        • Powell-Griner E.
        • et al.
        State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s.
        JAMA. 2002; 287: 2659-2667https://doi.org/10.1001/jama.287.20.2659
        • CDC
        State and sex specific prevalence of selected characteristics—Behavioral Risk Factor Surveillance System, 1996 and 1997.
        MMWR CDC Surveill Summ. 2000; 49: 1-39
        • CDC
        Surveillance for certain health behaviors among selected local areas—United States, Behavioral Risk Factor Surveillance System, 2011.
        MMWR CDC Surveill Summ. 2014; 63: 1-149
        • CDC
        Surveillance of influenza vaccination coverage—United States, 2007-08 through 2011-12 influenza seasons.
        MMWR Surveill Summ. 2013; 62: 1-29
      6. Guide to Community Preventive Services. www.thecommunityguide.org/index.html. Accessed August 8, 2015.

        • Johns T.L.
        • Roetzheim R.
        • Chen R.
        Predictors of tetanus-diphtheria-acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.
        J Prim Care Community Health. 2013; 4: 95-100https://doi.org/10.1177/2150131912455428
        • CDC
        Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy—16 States and New York City, 2011.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 522-526
        • CDC
        National and state vaccination coverage among adolescents aged 13-17 years—United States, 2013.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 625-633
        • Egede L.E.
        • Zheng D.
        Racial/ethnic differences in adult vaccination among individuals with diabetes.
        Am J Public Health. 2003; 93: 324-329https://doi.org/10.2105/AJPH.93.2.324
        • Schwartz K.L.
        • Neale V.A.
        • Northrup J.
        • et al.
        No racial differences in response to standardized offer of influenza vaccination: a Metronet study.
        J Gen Intern Med. 2006; 21: 346-351https://doi.org/10.1111/j.1525-1497.2006.00401.x
        • Lu P.J.
        • Byrd K.K.
        • Murphy T.V.
        • Weinbaum C.
        Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
        Vaccine. 2011; 29: 7049-7057https://doi.org/10.1016/j.vaccine.2011.07.030
        • Lu P.J.
        • Callahan D.B.
        • Ding H.
        • Euler G.L.
        Influenza A (H1N1) 2009 monovalent vaccination among adults aged 25-64 years with asthma—United States, 2010.
        Am J Prev Med. 2011; 41: 619-626https://doi.org/10.1016/j.amepre.2011.08.004
        • Lu P.J.
        • Nuorti J.P.
        Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009.
        Am J Epidemiol. 2012; 175: 827-837https://doi.org/10.1093/aje/kwr376
        • Sudano J.J.
        • Baker D.W.
        Intermittent lack of health insurance coverage and use of preventive services.
        Am J Public Health. 2003; 93: 130-137https://doi.org/10.2105/AJPH.93.1.130
        • Beal A.C.
        • Doty M.M.
        • Hernandez S.E.
        • Shea K.K.
        • Davis K.
        Closing the divide: how medical homes promote equity in health care—results from the Commonwealth Fund 2006 Health Care Quality Survey.
        The Commonwealth Fund, New York, NYMarch 31, 2015 (http://www.commonwealthfund.org/publications/fund-reports/2007/jun/closing-the-divide--how-medical-homes-promote-equity-in-health-care--results-from-the-commonwealth-f. Accessed March 31, 2015)
        • Lu P.J.
        • O’Halloran A.
        • Williams W.W.
        Impact of health insurance status on vaccination coverage among adult populations.
        Am J Prev Med. 2015; 48: 647-661https://doi.org/10.1016/j.amepre.2014.12.008
        • Shenson D.
        • Dimartino D.
        • Bolen J.
        • Campbell M.
        • Lu P.J.
        • Singleton J.A.
        Validation of self-reported pneumococcal vaccination in Behavioral Risk Factor Surveillance surveys: experience from the Sickness Prevention Achieved Through Regional Collaboration (SPARC) program.
        Vaccine. 2005; 23: 1015-1020https://doi.org/10.1016/j.vaccine.2004.07.039
        • Rolnick S.J.
        • Parker E.D.
        • Nordin J.D.
        • et al.
        Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?.
        Vaccine. 2013; 31: 3928-3935https://doi.org/10.1016/j.vaccine.2013.06.041
        • Poland G.A.
        • Shefer A.M.
        • McCauley M.
        • et al.
        Standards for adult immunization practice.
        Am J Prev Med. 2003; 25: 144-150https://doi.org/10.1016/S0749-3797(03)00120-X
        • Lindley M.C.
        • Horlick G.A.
        • Shefer A.M.
        • Shaw F.E.
        • Gorji M.
        Assessing state immunization requirements for healthcare workers and patients.
        Am J Prev Med. 2007; 32 (4594–4565)https://doi.org/10.1016/j.amepre.2007.02.009
        • National Vaccine Advisory Committee
        Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice.
        Public Health Rep. 2014; 129: 115-123
      7. 111th Congress. Public Law 111–148—March. 23, 2010. 124 STAT. 119 (H.R. 3590). An act entitled: the Patient Protection and Affordable Care Act. www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed September 5, 2013.

        • Koh H.K.
        • Sebelius K.G.
        Promoting prevention through the Affordable Care Act.
        N Engl J Med. 2010; 363: 1296-1299https://doi.org/10.1056/NEJMp1008560